Effect of Melatonin on vascular reactivity: a cross-over double blind study in post-menopausal women  by Modena, M.G. et al.
320A ,IAC(' I;¢!',, ilal'), lqqX 
chronic combined admlntstrati13n of vit13mln C and E can improve 13nd13th13- 
11131 function, we menaur13d f113w-mod113ted v,3nedl113tten (FMD, endotheltum- 
depend13nt vasedl113tlon) 13nd subtlngual glyc13ryl trinltmt13 Induc13d v~seddation 
(0,3 ms, GTN-D, ondothelium Independent vnsodilntton) In the brnchlnl ndery 
in 11 young chronic smok13rs aged 25 L 3 yeats by high rosolullon ultrttsou13d, 
FMD was m13asurod ,~s percent dt13meter chnngos from baseline to hyp13romlc 
conditions (1 mln ~lfter 5 sin occlusion of femerm artery), Each subjocle, had 
neither the other eomnnn/risk 113c(13m nor org,:lnlc dlseaso, FMD nnd GTN.D 
wore examined 0 limos in each ,ublect; at baseline, nf Iho end of 4 weeks 
oral administration of vitamin C (~ 9/dRy) rmd vitamin E (500 rag/day) 13nd Rt 4 
weeks alter cessation of vitamins, FMD wee slgniflc~ntly increased from u,~se. 
line In the treatment phase 13f vitamins and returned to baseline levels alter 
the oe.s~,~tlon, Vitnmtns had no affect on GTN.D, In ¢onclust13n, chronic corn. 
binod dleti't W t~Llpplomont of vitamin C ~nd E improves endothelial |unction 
nnd might h~vo provenlivo effect against the pmgret'~si13n of nthorasclorasis in 
smokes, H13w~ver, this bonefic~N 13fleet wt~ff rover~od ~fter cossnti13n, 
I~lll¢~etl~no Vd~mlns FIU 
FMD(%) 3~ t ~3 t~,7 ! ~1~' ,tt ~ 16 
GTN.I~ (%1 t~l  14(~ t32 lS4  t4t t,3a 
~ ]  The Determination of Peripheral Flow Mediated 
Vasodll~tlon Is a 8anoltlvo and 9pe¢~lfle Predl¢~tor 
fo r  the Presence o! Coronary Artery Dlee~ne 
~, ~lchroeder, M, Enderle, ROssen, A L~laumbelcb, C HeKteg, M, Plohl, 
K,K. Hesse, H,U, Hearing, K,R, K~mcJ~ FACC, FESC, Univer.'¢~fl, et
Tttpbln~n, GP~m~In~, 
B~Ickgmund: Penpher131 End131heltal Dysfunclton tED) q~,~anlihod by the do. 
termination of Flow Mediated Dilation (FMO%) of the brachtat artery usmg 
hlgh-rasohdion ultrasound has boon ~podod to be an early marker of athoro- 
n~lemsts, Although a poo~itlvn corml,~tion with Coronmy Artery Disease (CAD) 
m discussed, lt~e potentiality ef FMD% to predict presence o¢ absence of CAD 
was to evaluate 
Meth('~'~: In this pro,'~pccflvo, doub113.bllnd 13tudy we moasuiod FMD% as 
a marker of E D, Wn sh~d~od 122 patients without peer tnvas=ve coronary ding- 
oestic13 who were .~ch13dulod lot co[an~lry anglog~aphy because of the clinical 
s~,~.~pi~....~ of CAD (sO~ 80 m/34 f, ,3go 66 t 8.6 yearn, BMI 27.0 ~ ks!m;') 
Boforo cometary anglegraphy, FMD% was measured using h~gh-resolut=on 
uttr~l.~ound (13 Mhz). LongttudinN scans of the brachial arto~ were done on 
B-sod13 • 10 cm above the elbow, at ro~t, dunng roact=vo hyperemia and after 
sublingual admm=strahon of nitrogtyconno. We defined ED as FMD 4,5%. 
The presence of CAD was dehned es angtograph~eally vlowable lesions of 
any dogn.',o. Stat*stlcal analysis was portonnod by t-test, numbers are g~ven 
as moans  t ~r3, 
Re,~ults: Patients wilh CAD had a significantly lower FMD"o than ~'~banls 
wdhout CAD (37 t 41% vs 70t ~ EI,5'~o, p-value . 0.001) Based en FMD 
,45% as a cut-oil point tot ED a s~,nsitivity of 0.71 (72/I01), a specdicily 
Of O,Rl i17t21), a positive predictive value el 095 (72/'/'6) and a negatwo 
predictive value oi 0.37 (11/461 was calculated. 
Conclusions: The non-invasivo determination of Penpheml Endothelial 
Dysfunction according to ~mp~ired Flow Mediated Vasodilatien of the braehial 
~dory w~s found to be n specific and sensitive method to predict the pros- 
once of CAD. This approach warronts further evaluation to determine its role 
as an additional screonmg test to standoff1 methods in patients with chmcal 
suspicion of CAD, 
• Determination of Time to Maximal Flow-mediated, 
Endothelial-dependent Vasodilator Response of the 
Brachlal Artery 
J.A. Arrowood, R. Feozor, M,R. Fisher, P.V. Ravindra, R,G. Makhoul, 
J V. Nixon. Me~ Coil of VA, Richmond. VA. USA 
Measurement of the change m brachial artery diameter (BAD) by high reso- 
lution ultrasound in response to hyperemia can be used to assess endothe- 
hal-dependent vasodilation. The point in time when the maximal vasedilatory 
response occurs has not been well characterized. 
Objective. To determine the time course of vasodilation by measuring BAD 
every 5 sec for 90se~s after distal hyperemia created by 4 .~ sin of for¢arm 
circulatory arrest. 86 SUblects we.re studied 22 to 61 yrs in agu including 49 
(57%) with ask facto~; for CAD 
Results: are shown in the histogram. Average maximum % dilation was 
93 ~t: 19%, Only 45% of patients had maximal BAD 45-60 sec post stimulus, 
whereas 91% reached maximal BAD between 25-70 sec. 
Conclusion: Contrary to accepted practice, BAD should be measured con- 
tinuously between 30 and 70 sec post stimulus to ensure dote 3tion of maximal 
vasodilatory response. 
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~42-5~_ EffQct of Melatonln on Vaacular Rea=t!vlty; 
- - - - -  A Croaa-over Double Blind Study In 
Po=t, menopauaal Women 
M.G Mod013~, R R13ss|, R Molln~n, N Muir, G. Oegttam, F. C~onml, 
A, Andes, A, C~slelh Dpt of Card,gigs k It, Unwe:s~t],, ot & ~ ,  ttah/ 
B~ickgrouf}d Melatan,n (MELt is a natural hoffnone with seVoral sl.ip.~osed 
v0so~¢ftve praporbes 
&.fethect~ In order to test the effects el MEL on the en(lothehal function 
we podenned a double bhnd cross-ovo~ study versus placebo ~n 18 Consec- 
uhve posheen13p~usal women (mean age: $3.24 t 4.24 years) Wome. with 
diabetes, hypertension, I~yporchotosteralem~ a:,d smokers were exek~k.--,d 
E13ch woman was randomized to oral placebo or MEL at the dose o! I mg and 
the day after crossed.over to the opposite treatment. Endothelial dependent 
v{~sodilaflon was studied. I hour ~lte~ the assumption o1 the drug, by mes- 
sy.inns the changes in brachiat artery dlamotor (BAd) and IIow attar reacttve 
hypotom~a Endothelial mdependcnt vasodllat~on was measured 3 mmutes 
alter 400 ~ g of spray subhngual mtmgfycenn 
ResultS; 
~..~.abtes Placebo MEL p 
BAll. ms. base 4 r t 13 4 408 ~ 13 5 O 8 
ioacttvo hyporomlll 4 a t 13 4 4 ~ t O 6 0 6 
atlo~ ntbostyc,elm 5 e t 13 4 4 I~O .. e 4 0 2, 
now mediated ilation 8 2 t 4 I 15 4 I 6 t e 135, 
Flow. mr(ms, t~)so 50 3 ~ 16 O t4 4 ~ 25, | O 05, 
reactive hypo~omta 765, : 26 13 75, 5, ~ 25 0 138 
¢'~ltov nltloglycerm 53 6 ~ 23 0 556 ~ 10 O O 6 
Conclusten: MEL seems to have a positive inlluenco on endolhehal depen- 
dent vasoddabon 
~_~]  Cholesterol Lowering With Pravastatin Improves 
Resistance Artery Endothelial Function in Subjects 
With Normal Coronary  Ar ter iograms 
J.L. Houghton, EF. Phdbin, M.T. Torossov, R.G. Reed, T.A. Pearson. Albany 
Medical College. Albany, NY, USA 
Background Improvement in epicard~al and resistance coronary endethehal 
function after cholesterol Iowenng has been demonstrated in pts with overt 
CAD but not in hyperchotesterolemic pls with nl cor. 
Methods: Twenty-four euglycemic pts with elevated LDL chol ( : 130 mg~dl) 
were placed on an AHA lipid Iowenng diet for 12 wks and then underwent 
baseline endothelial function k;sting utilizing graded intracoronary infusions 
of ACh. 
Results: Of 24, 14 {58%) were tound to have an abnormal resistance artery 
ddator response to ACh I. 150°o increase) and were candidates for random- 
tzation. One subject was not randnmlzed becaus~ of dietary noncompliance. 
The remaining 13 were ranaomly assigned in a double blind fashion to recewe 
either pravastatin (20--40 mg per day) or placebo for 6 months. Endothelial 
function testing was then repeated using the identical protocol. Of 8 pts re- 
ceiving pravastatin, peak increase in coronary blood flow (CBF) was 97 
10°,o at basehne and 140 :.~ 18% during restudy (p = 0.06). In six of these 
with nlcor, peak increase in CBF was 97 ~ 13% at baseline and 160 ± 16% 
after p, ~vastatin (p = 0.01). LDL chol was 151 ~. 8 at baseline and 112 ± 7 
mgldl at restudy (p = 0.005), Of 5 receiving placebo, 2 were excluded; one 
because of a technically poor study and one because of noncompliance, In 
the 3 placebo pts, peak CBF responses were 110 ± 16% and 120 ± 27% 
increase, respectively (p = NS). LDL chol was unchanged at 182 ± 14 and 
187 ~ 18 mg/dl, 
Conclusion: Treatment with pravastatin over 6 mGnt:~s led to significant 
lowering of LDL chol a,~d improved resistance artery ,,ndothelial function 
among pts with nl cor. Pt~cebo controls did not show this Oenefit. 
